US Stock MarketDetailed Quotes
JAZZ Jazz Pharmaceuticals
- 121.590
- -1.050-0.86%
Close Nov 29 13:00 ET
- 121.590
- 0.0000.00%
Post 17:01 ET
7.35BMarket Cap17.22P/E (TTM)
123.180High121.050Low286.84KVolume122.890Open122.640Pre Close34.94MTurnover0.49%Turnover Ratio19.93P/E (Static)60.45MShares134.17052wk High1.76P/B7.13BFloat Cap99.06052wk Low--Dividend TTM58.67MShs Float194.730Historical High--Div YieldTTM1.74%Amplitude0.515Historical Low121.806Avg Price1Lot Size
Jazz Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.52%1.05B | 6.95%1.02B | 1.03%901.98M | 4.78%3.83B | 4.10%1.01B | 3.35%972.14M | 2.62%957.32M | 9.72%892.81M | 18.26%3.66B | 8.41%972.12M |
| Operating revenue | 8.52%1.05B | 6.95%1.02B | 1.03%901.98M | 4.78%3.83B | 4.10%1.01B | 3.35%972.14M | 2.62%957.32M | 9.72%892.81M | 18.26%3.66B | 8.41%972.12M |
| Cost of revenue | 9.26%111.61M | 12.68%109.9M | -25.77%95.49M | -19.41%435.58M | -35.92%107.24M | -23.57%102.15M | -21.47%97.54M | 11.59%128.64M | 22.63%540.52M | 22.92%167.36M |
| Gross profit | 8.43%943.36M | 6.30%913.92M | 5.54%806.5M | 8.97%3.4B | 12.42%904.69M | 7.81%869.99M | 6.32%859.78M | 9.41%764.17M | 17.54%3.12B | 5.81%804.76M |
| Operating expense | -2.07%683.15M | 1.76%714.48M | 14.62%730.29M | 7.46%2.8B | 10.25%764.2M | 7.56%697.6M | 7.37%702.14M | 4.29%637.11M | 4.97%2.61B | -2.54%693.15M |
| Selling and administrative expenses | 5.66%325.77M | -0.68%338.52M | 18.06%351.71M | -5.21%1.34B | 3.35%396.03M | -13.99%308.31M | -6.99%340.84M | -3.53%297.92M | -2.39%1.42B | -3.83%383.2M |
| Research and development costs | -14.71%199.92M | 5.49%220.73M | 17.65%222.85M | 43.90%849.66M | 25.53%216.61M | 57.45%234.4M | 50.48%209.24M | 45.72%189.41M | 16.75%590.45M | 11.01%172.56M |
| Depreciation amortization depletion | 1.66%157.46M | 2.08%155.22M | 3.97%155.73M | 1.52%608.28M | 10.31%151.55M | 9.67%154.88M | 2.43%152.06M | -12.96%149.79M | 13.96%599.17M | -12.66%137.39M |
| -Depreciation and amortization | 1.66%157.46M | 2.08%155.22M | 3.97%155.73M | 1.52%608.28M | 10.31%151.55M | 9.67%154.88M | 2.43%152.06M | -12.96%149.79M | 13.96%599.17M | -12.66%137.39M |
| Operating profit | 50.94%260.21M | 26.52%199.44M | -40.02%76.21M | 16.65%597.58M | 25.88%140.5M | 8.83%172.39M | 1.90%157.64M | 45.12%127.06M | 200.84%512.27M | 126.03%111.61M |
| Net non-operating interest income expense | 17.90%-58.7M | 15.58%-62.02M | 10.83%-66.12M | -0.41%-289.44M | 5.13%-70.32M | 10.90%-71.5M | -16.27%-73.47M | -4.90%-74.15M | -3.40%-288.24M | 16.34%-74.13M |
| Non-operating interest expense | -17.90%58.7M | -15.58%62.02M | -10.83%66.12M | 0.41%289.44M | -5.13%70.32M | -10.90%71.5M | 16.27%73.47M | 4.90%74.15M | 3.40%288.24M | -16.34%74.13M |
| Other net income (expense) | 49.09%-701K | 121.28%507K | -633.20%-11.69M | 98.29%-10.21M | 97.71%-8.65M | 99.00%-1.38M | 96.62%-2.38M | 120.81%2.19M | -13,619.77%-596.81M | -6,626.34%-377.48M |
| Gain on sale of security | 49.09%-701K | 121.28%507K | -153.02%-1.69M | 146.21%8.79M | 476.83%9.35M | 70.38%-1.38M | -77.36%-2.38M | 130.29%3.19M | -337.10%-19.01M | 55.77%-2.48M |
| Special income (charges) | --0 | --0 | -900.00%-10M | 96.71%-19M | 95.20%-18M | --0 | --0 | ---1M | ---577.8M | ---375M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --133.65M | --0 |
| -Less:Other special charges | ---- | ---- | 900.00%10M | -95.72%19M | -95.20%18M | ---- | ---- | --1M | --444.15M | --375M |
| Income before tax | 101.78%200.81M | 68.65%137.93M | -102.91%-1.6M | 179.92%297.93M | 118.10%61.53M | 265.50%99.52M | 289.19%81.78M | 771.16%55.1M | -230.37%-372.78M | -658.41%-339.99M |
| Income tax | 69.19%-14.53M | -26.02%-30.65M | 176.15%11.67M | 24.41%-119.91M | 66.92%-33.09M | -9.64%-47.18M | -50.96%-24.32M | -2,958.96%-15.32M | -173.41%-158.65M | -702.45%-100.04M |
| Earnings from equity interest net of tax | -326.19%-285K | 99.28%-12K | -34.03%-1.35M | 69.67%-3.01M | 40.36%-461K | 104.95%126K | 32.18%-1.67M | 75.74%-1.01M | -1,289.50%-9.92M | 74.13%-773K |
| Net income | 46.48%215.06M | 61.40%168.57M | -121.06%-14.62M | 285.14%414.83M | 139.11%94.15M | 847.25%146.82M | 201.28%104.44M | 4,114.94%69.42M | 32.03%-224.06M | -580.95%-240.72M |
| Net income continuous Operations | 46.48%215.06M | 61.40%168.57M | -121.06%-14.62M | 285.14%414.83M | 139.11%94.15M | 847.25%146.82M | 201.28%104.44M | 4,114.94%69.42M | 32.03%-224.06M | -580.95%-240.72M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 46.48%215.06M | 61.40%168.57M | -121.06%-14.62M | 285.14%414.83M | 139.11%94.15M | 847.25%146.82M | 201.28%104.44M | 4,114.94%69.42M | 32.03%-224.06M | -580.95%-240.72M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 46.48%215.06M | 61.40%168.57M | -121.06%-14.62M | 285.14%414.83M | 139.11%94.15M | 847.25%146.82M | 201.28%104.44M | 4,114.94%69.42M | 32.03%-224.06M | -580.95%-240.72M |
| Basic earnings per share | 50.21%3.5 | 64.42%2.68 | -121.10%-0.23 | 282.96%6.55 | 139.27%1.5 | 851.61%2.33 | 191.07%1.63 | 3,533.33%1.09 | 35.14%-3.58 | -570.18%-3.82 |
| Diluted earnings per share | 59.81%3.42 | 63.82%2.49 | -122.12%-0.23 | 270.39%6.1 | 137.17%1.42 | 790.32%2.14 | 176.36%1.52 | 3,366.67%1.04 | 35.14%-3.58 | -570.18%-3.82 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data